What are the major opportunities in the Opioid-Induced Constipation Treatment market? What are the strategies for the Opioid-Induced Constipation Treatment market?

For detailed insights on the major opportunities and strategies in the Opioid-Induced Constipation Treatment market, Read More

How does the Opioid-Induced Constipation Treatment market relate to the overall economy and other similar markets?

For detailed insights on Opioid-Induced Constipation Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Opioid-Induced Constipation Treatment market growth? SWOT analysis of the Opioid-Induced Constipation Treatment market.

For detailed insights on the key dynamics influencing the Opioid-Induced Constipation Treatment market growth and SWOT analysis of the Opioid-Induced Constipation Treatment industry, Read More

Global Opioid-Induced Constipation Treatment Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Opioid-Induced Constipation Treatment Global Market Report 2025

Name: Opioid-Induced Constipation Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Drug Class (Laxatives, Peripherally Acting µ-opioid Receptor Antagonists, Serotonin Receptor Agonists, Prostaglandin), By Type (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Opioid-Induced Constipation Treatment Market Overview

• Opioid-Induced Constipation Treatment market size has reached to $1.78 billion in 2024

• Expected to grow to $2.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%

• Growth Driver: Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipation Treatment Market

• Market Trend: Strategic Partnerships Driving Innovation In Opioid-Induced Constipation Treatment

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Opioid-Induced Constipation Treatment Market?

Opioid-induced constipation (OIC) treatment refers to the various approaches and medications used to manage constipation caused by the use of opioid medications. These treatments aim to alleviate the symptoms of constipation without compromising the pain-relieving effects of opioids, thereby improving the patient's overall quality of life and maintaining effective pain management with both pharmacological with non-pharmacological approaches.

The drug classes of opioid-induced constipation treatment include laxatives, peripherally acting mu-opioid receptor antagonists, serotonin receptor agonists, and prostaglandin. Laxatives are medications used to promote bowel movements and relieve constipation by increasing stool frequency and softening stool consistency. They can be administered through various types or routes including oral and parenteral including subcutaneous injection and distributed through hospital pharmacies, online pharmacies, and Retail pharmacies.

Opioid-Induced Constipation Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Opioid-Induced Constipation Treatment Market Size 2025 And Growth Rate?

What Is The Opioid-Induced Constipation Treatment Market Growth Forecast?

The opioid-induced constipation treatment market size is expected to see strong growth in the next few years. It will grow to $2.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to accelerated drug approval initiatives, increasing use of opioid analgesic prescriptions, surging expenditure on the R And D of novel treatments, and an increase in development of biologics. Major trends in the forecast period include patient education and awareness, the emergence of targeted therapies, non-pharmacological interventions, biotechnology innovations, and increased investment.

The forecast of 6.3% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. medical supply chains by increasing costs for peripherally acting mu-opioid receptor antagonists (PAMORAs) imported from Ireland and India, potentially leading to increased opioid-related complications and higher gastroenterology prescription expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Opioid-Induced Constipation Treatment Market Segmented?

1) By Drug Class: Laxatives, Peripherally Acting µ-opioid Receptor Antagonists, Serotonin Receptor Agonists, Prostaglandin

2) By Type: Oral, Parenteral

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

Subsegments:

1) By Laxatives: Osmotic Laxatives, Stimulant Laxatives, Bulk-Forming Laxatives

2) By Peripherally Acting µ-Opioid Receptor Antagonists: Naloxegol, Methylnaltrexone, Alvimopan

3) By Serotonin Receptor Agonists: Prucalopride, Tegaserod

4) By Prostaglandin: Lubiprostone

What Is Driving The Opioid-Induced Constipation Treatment Market? Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipation Treatment Market

The rise in the administration of opioids for cancer and non-cancer pain is expected to propel the growth of the opioid-induced constipation treatment market going forward. Cancer pain refers to pain associated with cancer and its treatment, while non-cancer pain refers to pain from conditions unrelated to cancer. Administration of opioids for cancer and non-cancer pain is driven by the need to effectively manage moderate to severe pain, considering factors such as the intensity and duration of pain, patient response to other treatments, and the overall goal of improving quality of life while minimizing potential risks of addiction and side effects. Opioid-induced constipation (OIC) treatment helps patients with cancer and non-cancer pain by relieving constipation caused by opioid use, thereby improving overall comfort, adherence to pain management regimens, and quality of life without compromising pain relief. For instance, in May 2021, according to the Government of Canada, a Canada-based federal administration, up to 8.3 million Canadians may experience chronic pain by 2025, and IT is expected to reach up to 9.0 million by 2030. Therefore, the rise in the administration of opioids for cancer and non-cancer pain is driving the growth of the opioid-induced constipation treatment industry.

Who Are The Major Players In The Global Opioid-Induced Constipation Treatment Market?

Major companies operating in the opioid-induced constipation treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Chemical Pharma Co. Ltd., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH., Shionogi & Co. Ltd., Ono Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Mundipharma International Limited, Lantheus Holdings Inc., Indivior plc, Mallinckrodt Pharmaceuticals, Collegium Pharmaceutical Inc., Ironwood Pharmaceuticals Inc., Cosmo Pharmaceuticals SA, Nektar Therapeutics, RedHill Biopharma Ltd., Theravance Biopharma Inc., Cumberland Pharmaceuticals Inc., Valinor Pharma LLC

What Are The Key Trends Of The Global Opioid-Induced Constipation Treatment Market? Strategic Partnerships Driving Innovation In Opioid-Induced Constipation Treatment

Major companies operating in the opioid-induced constipation treatment market are adopting strategic partnerships approach to develop innovative medicines. Strategic partnerships help opioid-induced constipation treatment companies by combining resources and expertise, enhancing research and development capabilities, expanding market reach, and accelerating commercialization, ultimately driving innovation and growth in the opioid-induced constipation treatment industry. For instance, in November 2022, Kyowa Kirin Co. Ltd, a Japan-based biotechnology company, partnered with Grünenthal GmbH, Germany-based pharmaceutical company to integrate the solutions for patients. With this partnership, they aim to enhance the growth and global availability of a portfolio of life-changing pain management medicines, including treatments for opioid-induced constipation, breakthrough cancer pain, and osteoporosis.

Need data on a specific region in this market?

Request Customisation

What Are Latest Mergers And Acquisitions In The Opioid-Induced Constipation Treatment Market? Grünenthal And Kyowa Kirin Enter Joint Venture To Market Pain Management And OIC Medications

In August 2023, Grünenthal GmbH, a Germany-based pharmaceutical company completed a joint venture collaboration with Kyowa Kirin International. This collaboration includes a portfolio of 13 brands across six therapeutic areas, with a primary focus on pain management, including medications for breakthrough cancer pain, opioid-induced constipation, and osteoporosis. Grünenthal owns a 51% majority share in the joint venture collaboration, while Kyowa Kirin owns a 49% share. Grünenthal intends to acquire the remaining 49% share at the beginning of 2026. Kyowa Kirin International is a Japan-based pharmaceutical company developing medication for opioid-induced constipation including peripherally acting mu-opioid receptor antagonists.

What Is The Regional Outlook For The Global Opioid-Induced Constipation Treatment Market?

North America was the largest region in the opioid-induced constipation treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Opioid-Induced Constipation Treatment Market?

The opioid-induced constipation treatment market includes revenues earned by entities by providing services such as medical consultation, dietary and lifestyle counselling, diagnostic and telehealth services. The market value includes the value of related goods sold by the service provider or included within the service offering. The opioid-induced constipation treatment market also includes sales of tablets, injections, syrups, fibre supplements, lubricants, enemas, suppositories and probiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Opioid-Induced Constipation Treatment Industry?

The opioid-induced constipation treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the opioid-induced constipation treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Opioid-Induced Constipation Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.9 billion
Revenue Forecast In 2034	$2.42 billion
Growth Rate	CAGR of 6.3% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Drug Class: Laxatives, Peripherally Acting µ-opioid Receptor Antagonists, Serotonin Receptor Agonists, Prostaglandin 2) By Type: Oral, Parenteral 3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies Subsegments: 1) By Laxatives: Osmotic Laxatives, Stimulant Laxatives, Bulk-Forming Laxatives 2) By Peripherally Acting µ-Opioid Receptor Antagonists: Naloxegol, Methylnaltrexone, Alvimopan 3) By Serotonin Receptor Agonists: Prucalopride, Tegaserod 4) By Prostaglandin: Lubiprostone
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Chemical Pharma Co. Ltd., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH., Shionogi & Co. Ltd., Ono Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Mundipharma International Limited, Lantheus Holdings Inc., Indivior plc, Mallinckrodt Pharmaceuticals, Collegium Pharmaceutical Inc., Ironwood Pharmaceuticals Inc., Cosmo Pharmaceuticals SA, Nektar Therapeutics, RedHill Biopharma Ltd., Theravance Biopharma Inc., Cumberland Pharmaceuticals Inc., Valinor Pharma LLC
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Opioid-Induced Constipation Treatment Market Characteristics

3. Opioid-Induced Constipation Treatment Market Trends And Strategies

4. Opioid-Induced Constipation Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Opioid-Induced Constipation Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Opioid-Induced Constipation Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Opioid-Induced Constipation Treatment Market Growth Rate Analysis

5.4. Global Opioid-Induced Constipation Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Opioid-Induced Constipation Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Opioid-Induced Constipation Treatment Total Addressable Market (TAM)

6. Opioid-Induced Constipation Treatment Market Segmentation

6.1. Global Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Laxatives

Peripherally Acting Mu-opioid Receptor Antagonists

Serotonin Receptor Agonists

Prostaglandin

6.2. Global Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

6.3. Global Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

6.4. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Osmotic Laxatives

Stimulant Laxatives

Bulk-Forming Laxatives

6.5. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Peripherally Acting µ-Opioid Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Naloxegol

Methylnaltrexone

Alvimopan

6.6. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Serotonin Receptor Agonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prucalopride

Tegaserod

6.7. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Prostaglandin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lubiprostone

7. Opioid-Induced Constipation Treatment Market Regional And Country Analysis

7.1. Global Opioid-Induced Constipation Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Opioid-Induced Constipation Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Opioid-Induced Constipation Treatment Market

8.1. Asia-Pacific Opioid-Induced Constipation Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Opioid-Induced Constipation Treatment Market

9.1. China Opioid-Induced Constipation Treatment Market Overview

9.2. China Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Opioid-Induced Constipation Treatment Market

10.1. India Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Opioid-Induced Constipation Treatment Market

11.1. Japan Opioid-Induced Constipation Treatment Market Overview

11.2. Japan Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Opioid-Induced Constipation Treatment Market

12.1. Australia Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Opioid-Induced Constipation Treatment Market

13.1. Indonesia Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Opioid-Induced Constipation Treatment Market

14.1. South Korea Opioid-Induced Constipation Treatment Market Overview

14.2. South Korea Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Opioid-Induced Constipation Treatment Market

15.1. Western Europe Opioid-Induced Constipation Treatment Market Overview

15.2. Western Europe Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Opioid-Induced Constipation Treatment Market

16.1. UK Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Opioid-Induced Constipation Treatment Market

17.1. Germany Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Opioid-Induced Constipation Treatment Market

18.1. France Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Opioid-Induced Constipation Treatment Market

19.1. Italy Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Opioid-Induced Constipation Treatment Market

20.1. Spain Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Opioid-Induced Constipation Treatment Market

21.1. Eastern Europe Opioid-Induced Constipation Treatment Market Overview

21.2. Eastern Europe Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Opioid-Induced Constipation Treatment Market

22.1. Russia Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Opioid-Induced Constipation Treatment Market

23.1. North America Opioid-Induced Constipation Treatment Market Overview

23.2. North America Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Opioid-Induced Constipation Treatment Market

24.1. USA Opioid-Induced Constipation Treatment Market Overview

24.2. USA Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Opioid-Induced Constipation Treatment Market

25.1. Canada Opioid-Induced Constipation Treatment Market Overview

25.2. Canada Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Opioid-Induced Constipation Treatment Market

26.1. South America Opioid-Induced Constipation Treatment Market Overview

26.2. South America Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Opioid-Induced Constipation Treatment Market

27.1. Brazil Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Opioid-Induced Constipation Treatment Market

28.1. Middle East Opioid-Induced Constipation Treatment Market Overview

28.2. Middle East Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Opioid-Induced Constipation Treatment Market

29.1. Africa Opioid-Induced Constipation Treatment Market Overview

29.2. Africa Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Opioid-Induced Constipation Treatment Market Competitive Landscape And Company Profiles

30.1. Opioid-Induced Constipation Treatment Market Competitive Landscape

30.2. Opioid-Induced Constipation Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Opioid-Induced Constipation Treatment Market Other Major And Innovative Companies

31.1. Takeda Pharmaceutical Company Limited

31.2. Daiichi Sankyo Chemical Pharma Co. Ltd.

31.3. Bausch Health Companies Inc.

31.4. Boehringer Ingelheim International GmbH.

31.5. Shionogi & Co. Ltd.

31.6. Ono Pharmaceutical Co. Ltd.

31.7. Dr. Reddy's Laboratories Ltd.

31.8. Hikma Pharmaceuticals plc

31.9. Mundipharma International Limited

31.10. Lantheus Holdings Inc.

31.11. Indivior plc

31.12. Mallinckrodt Pharmaceuticals

31.13. Collegium Pharmaceutical Inc.

31.14. Ironwood Pharmaceuticals Inc.

31.15. Cosmo Pharmaceuticals SA

32. Global Opioid-Induced Constipation Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Opioid-Induced Constipation Treatment Market

34. Recent Developments In The Opioid-Induced Constipation Treatment Market

35. Opioid-Induced Constipation Treatment Market High Potential Countries, Segments and Strategies

35.1 Opioid-Induced Constipation Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Opioid-Induced Constipation Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Opioid-Induced Constipation Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Peripherally Acting µ-Opioid Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Serotonin Receptor Agonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Prostaglandin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Opioid-Induced Constipation Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Opioid-Induced Constipation Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: Merck & Co. Inc. Financial Performance

Table 80: Bayer AG Financial Performance

Table 81: Sanofi S.A. Financial Performance

Table 82: AstraZeneca plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Peripherally Acting µ-Opioid Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Serotonin Receptor Agonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Prostaglandin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Opioid-Induced Constipation Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Opioid-Induced Constipation Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Merck & Co. Inc. Financial Performance

Figure 80: Bayer AG Financial Performance

Figure 81: Sanofi S.A. Financial Performance

Figure 82: AstraZeneca plc Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Corporate Identity Design Global Market Report 2025 – By Type (Logo Design, Identity Design, Brand Design), By Company Size (Small And Medium Enterprises, Large Enterprises), By Application (Business, Government, Other A...

View Report

Air Management System Global Market Report 2025 – By System (Thermal Management System, Engine Bleed Air System, Oxygen Systems, Fuel Tank Inerting Systems, Cabin Pressure Control System, Ice Protection System), By Platf...

View Report

Provider Lifecycle Management Global Market Report 2025 – By Solutions (Recruitment, Credentialing, Online Application, Contracting, Data Management, Finder Services), By Deployment (On-Premises, Cloud-Based), By End Use...

View Report

Web Content Management Global Market Report 2025 – By Component( Solutions, Service ), By Organization Size( Large Enterprises, Small And Medium-Sized Enterprises (SMES)), By Deployment Mode( On-Premises, Cloud), By Vert...

View Report

Laryngeal Cancer Therapeutics Global Market Report 2025 – By Treatment Type (Chemotherapy, Immunotherapy, Other Treatments), By Route Of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Onli...

View Report

Composites Repair And Rehab Global Market Report 2025 – By Product (Glass Fiber Composites, Carbon Fiber Composite, Other Products), By Process (Hand Lay-up, Vacuum Infusion, Autoclave, Other Processes), By Application (...

View Report

Teleradiology Global Market Report 2025 – By Modality (X-Ray, MRI, CT Scan, Ultrasound Systems), By Technology (Web Based, Cloud Based), By Component (Hardware, Software), By End User (Hospitals, Diagnostic Centers, Othe...

View Report

Gastrointestinal Drugs Market 2022 - By Type (Antacids, Antiulcerants, Antiemetics and Antinauseants, Antidiarrheals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Root of Administrat...

View Report

Frequently Asked Questions

What is the definition of the Opioid-Induced Constipation Treatment market?

How will the Opioid-Induced Constipation Treatment market drivers and restraints affect the market dynamics? What forces will shape the Opioid-Induced Constipation Treatment industry going forward?

The market major growth driver - Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipation Treatment Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Opioid-Induced Constipation Treatment market?

The opioid-induced constipation treatment market size has grown strongly in recent years. It will grow from $1.78 billion in 2024 to $1.9 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to expanding geriatric population, personalized OIC treatments, availability of effective OIC drugs, increasing prevalence of opioid use, and rising prevalence of gastrointestinal disorders. The opioid-induced constipation treatment market size is expected to see strong growth in the next few years. It will grow to " $2.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to accelerated drug approval initiatives, increasing use of opioid analgesic prescriptions, surging expenditure on the R And D of novel treatments, and an increase in development of biologics. Major trends in the forecast period include patient education and awareness, the emergence of targeted therapies, non-pharmacological interventions, biotechnology innovations, and increased investment. For further insights on this market, request a sample here

How is the Opioid-Induced Constipation Treatment market segmented?

The opioid-induced constipation treatmentmarket covered in this report is segmented –
1) By Drug Class: Laxatives; Peripherally Acting µ-opioid Receptor Antagonists; Serotonin Receptor Agonists; Prostaglandin
2) By Type: Oral; Parenteral
3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies Subsegments:
1) By Laxatives: Osmotic Laxatives; Stimulant Laxatives; Bulk-Forming Laxatives
2) By Peripherally Acting µ-Opioid Receptor Antagonists: Naloxegol; Methylnaltrexone; Alvimopan
3) By Serotonin Receptor Agonists: Prucalopride; Tegaserod
4) By Prostaglandin: Lubiprostone For further insights on this market, request a sample here

Which region has the largest share of the Opioid-Induced Constipation Treatment market? What are the other regions covered in the report?

North America was the largest region in the opioid-induced constipation treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioid-induced constipation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the Opioid-Induced Constipation Treatment market?

What are the key trends in the Opioid-Induced Constipation Treatment market?

Major trends in this market include Strategic Partnerships Driving Innovation In Opioid-Induced Constipation Treatment. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Opioid-Induced Constipation Treatment Global Market Report 2025

Opioid-Induced Constipation Treatment Market Overview

What Is Covered Under Opioid-Induced Constipation Treatment Market?

What Is The Opioid-Induced Constipation Treatment Market Size 2025 And Growth Rate?

What Is The Opioid-Induced Constipation Treatment Market Growth Forecast?

What’s The Trade War Impact On Healthcare Services Industry?

How Is The Opioid-Induced Constipation Treatment Market Segmented?

What Is Driving The Opioid-Induced Constipation Treatment Market? Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipation Treatment Market

Who Are The Major Players In The Global Opioid-Induced Constipation Treatment Market?

What Are The Key Trends Of The Global Opioid-Induced Constipation Treatment Market? Strategic Partnerships Driving Innovation In Opioid-Induced Constipation Treatment

What Are Latest Mergers And Acquisitions In The Opioid-Induced Constipation Treatment Market? Grünenthal And Kyowa Kirin Enter Joint Venture To Market Pain Management And OIC Medications

What Is The Regional Outlook For The Global Opioid-Induced Constipation Treatment Market?

What Defines the Opioid-Induced Constipation Treatment Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Opioid-Induced Constipation Treatment Industry?

Opioid-Induced Constipation Treatment Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions